A new study finds that misdirected immune responses can persist for months in those who are suffering from long COVID-19.
A physician-bioethicist reflects on how health professionals are yet again facing painful reminders of the early months of the pandemic.
ECMO uses an artificial heart and lung to replace the entire function of the person’s own heart and lungs outside the body. And COVID is demanding more ECMO than we’ve ever used before.
Who gets scarce life-saving resources when hospitals are overwhelmed? And how are these decisions made? State and territory governments are yet to answer these difficult questions.
Plasma therapy sounded great at the start of the pandemic. Give COVID patients blood plasma from people who had recovered. But the evidence is in. It doesn’t work.
Medications to treat COVID-19 are in no way a substitute for the vaccine. But under the right circumstances, some show great promise for helping patients.
The term ‘intubation’ is used when experts talk about treating patients with severe COVID-19. But this medical term doesn’t explain the traumatic procedure involved.
The hospital system is already strained. And this is what we face as Australia prepares to open up.
COVID patients in ICU are younger, sicker and stay for longer than other critically unwell patients, affecting the entire hospital and its staff.
It seems things have shifted slightly since earlier in the pandemic. A growing proportion of people hospitalised with the Delta strain are aged in their 30s or 40s.
A year after it became clear that COVID-19 was becoming a pandemic, there is still no cure, but doctors have several innovative treatments. Some are keeping patients out of the hospital entirely.
Lockdown is a drastic solution to limit the impact of COVID-19 and has many costs, as this long read explains.
Three new studies show corticosteroids can reduce deaths in critically ill COVID-19 patients. But what about other patients?
In the event COVID-19 sees ICU resources stretched too thin, Victoria doesn’t have clear, uniform or transparent guidelines outlining who should be prioritised for care.
Studies like this are important because they help gather data from an African perspective.
A bioethicist argues that the problem of health disparities existed long before COVID-19 struck with a vengeance in marginalized communities.
Is it possible that people who recover from COVID-19 will be plagued with long term side effects from the infection? An infectious disease physician reviews the evidence so far.
The only chaplain in the COVID-19 section of a Montréal hospital offers spiritual care to patients and families, as well to staff, who have found themselves more intimately exposed to life and death.
A recent study suggested the coronavirus could spread up to four metres. But the evidence isn’t strong enough to suggest we should change social distancing advice from 1.5 metres.
It’s time to talk to your loved ones about what care and treatment you’d want if you face death from COVID-19.